HME EJENDOMSSELSKAB ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.4% 3.7% 2.8% 2.1% 1.7%  
Credit score (0-100)  56 51 58 66 72  
Credit rating  BBB BBB BBB A A  
Credit limit (kDKK)  0.0 0.0 0.0 0.1 2.5  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  181 204 231 275 304  
EBITDA  -104 -98.3 130 275 304  
EBIT  -209 -212 0.8 131 160  
Pre-tax profit (PTP)  -245.6 -236.6 -60.9 80.8 57.9  
Net earnings  -176.3 -227.4 13.3 80.8 57.9  
Pre-tax profit without non-rec. items  -246 -237 -60.9 80.8 57.9  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  2,619 3,042 4,123 4,003 3,859  
Shareholders equity total  1,666 1,439 1,452 1,533 1,590  
Interest-bearing liabilities  929 1,468 2,548 2,361 2,823  
Balance sheet total (assets)  2,803 3,187 4,221 4,112 4,632  

Net Debt  839 1,426 2,548 2,361 2,060  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  181 204 231 275 304  
Gross profit growth  -2.9% 12.7% 13.3% 18.8% 10.5%  
Employees  1 1 1 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,803 3,187 4,221 4,112 4,632  
Balance sheet change%  -6.4% 13.7% 32.4% -2.6% 12.7%  
Added value  -208.9 -212.4 0.8 130.6 159.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -209 309 952 -264 -288  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 1.0 2.0 3.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -115.3% -104.0% 0.3% 47.5% 52.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -7.2% -7.1% 0.0% 3.1% 3.7%  
ROI %  -7.4% -7.3% 0.0% 3.2% 3.7%  
ROE %  -10.1% -14.6% 0.9% 5.4% 3.7%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  59.8% 45.6% 34.7% 37.6% 34.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -804.5% -1,450.8% 1,960.6% 859.2% 678.6%  
Gearing %  55.8% 102.1% 175.5% 154.1% 177.5%  
Net interest  0 0 0 0 0  
Financing costs %  3.9% 2.0% 3.1% 2.0% 3.9%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.2 0.1 0.0 0.0 0.3  
Current Ratio  0.2 0.1 0.0 0.0 0.3  
Cash and cash equivalent  90.5 42.6 0.0 0.0 762.3  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -801.8 -1,452.4 -2,519.8 -2,318.8 -2,116.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  -209 -212 1 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -104 -98 130 0 0  
EBIT / employee  -209 -212 1 0 0  
Net earnings / employee  -176 -227 13 0 0